🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/07/2023 | 107,24 | 107,62 | 105,17 | 105,27 | -1,75% | 2,28% | 9.813.100 |
| 26/07/2023 | 106,80 | 108,01 | 106,06 | 107,14 | -0,36% | 1,83% | 7.042.700 |
| 25/07/2023 | 107,64 | 108,72 | 107,32 | 107,53 | -1,16% | 1,30% | 6.498.700 |
| 24/07/2023 | 109,99 | 110,34 | 108,50 | 108,79 | -1,45% | 1,67% | 6.045.500 |
| 21/07/2023 | 108,73 | 110,62 | 108,38 | 110,39 | +1,78% | 2,06% | 8.194.000 |
| 20/07/2023 | 106,55 | 108,95 | 106,06 | 108,46 | +2,37% | 2,71% | 8.073.000 |
| 19/07/2023 | 106,16 | 107,38 | 105,91 | 105,95 | +0,00% | 1,38% | 6.608.600 |
| 18/07/2023 | 105,88 | 107,03 | 105,35 | 105,95 | +0,36% | 1,59% | 7.499.100 |
| 17/07/2023 | 107,04 | 107,44 | 105,29 | 105,57 | -1,65% | 2,01% | 7.376.400 |
| 14/07/2023 | 106,26 | 107,68 | 106,26 | 107,34 | +0,96% | 1,34% | 7.209.900 |
| 13/07/2023 | 107,33 | 107,91 | 106,26 | 106,32 | -1,07% | 1,54% | 9.764.400 |
| 12/07/2023 | 108,37 | 109,05 | 107,19 | 107,47 | -1,13% | 1,72% | 8.376.700 |
| 11/07/2023 | 109,48 | 110,02 | 108,25 | 108,70 | -1,15% | 1,62% | 6.084.400 |
| 10/07/2023 | 109,14 | 110,60 | 109,10 | 109,96 | +0,88% | 1,37% | 5.949.200 |
| 07/07/2023 | 111,07 | 111,50 | 108,76 | 109,00 | -2,46% | 2,47% | 11.316.600 |
| 06/07/2023 | 112,90 | 113,44 | 111,71 | 111,75 | -1,72% | 1,53% | 7.257.400 |
| 05/07/2023 | 114,04 | 114,43 | 113,42 | 113,70 | -0,55% | 0,89% | 5.861.500 |
| 03/07/2023 | 114,47 | 114,62 | 113,53 | 114,33 | -0,92% | 0,95% | 2.834.600 |
| 30/06/2023 | 113,79 | 115,61 | 113,43 | 115,39 | +1,63% | 1,92% | 8.090.600 |
| 29/06/2023 | 112,25 | 113,88 | 111,81 | 113,54 | +0,98% | 1,84% | 6.281.800 |
| 28/06/2023 | 113,45 | 113,57 | 111,44 | 112,44 | -0,78% | 1,88% | 8.173.800 |
| 27/06/2023 | 112,83 | 113,71 | 111,87 | 113,32 | +0,21% | 1,63% | 7.093.900 |
| 26/06/2023 | 114,44 | 114,60 | 111,78 | 113,08 | -1,33% | 2,46% | 7.685.100 |
| 23/06/2023 | 114,16 | 114,91 | 113,02 | 114,60 | +0,77% | 1,66% | 16.407.900 |
| 22/06/2023 | 111,60 | 113,84 | 111,60 | 113,72 | +2,30% | 2,01% | 7.884.100 |
| 21/06/2023 | 110,11 | 111,52 | 109,52 | 111,16 | +0,84% | 1,82% | 6.854.800 |
| 20/06/2023 | 109,08 | 110,86 | 109,03 | 110,23 | +0,83% | 1,68% | 7.744.400 |
| 16/06/2023 | 109,50 | 110,46 | 109,06 | 109,32 | -0,07% | 1,28% | 15.844.300 |
| 15/06/2023 | 108,40 | 109,90 | 108,34 | 109,40 | +0,68% | 1,44% | 7.305.700 |
| 14/06/2023 | 109,72 | 109,93 | 108,35 | 108,66 | -1,21% | 1,44% | 6.137.300 |